Clinical Trials Sponsored by Sture Andersson

Total 3110 results

Sture Andersson

Unknown

Inhaled Salbutamol in Elective Caesarean Section (SAISTY)

Cesarean Section | Postnatal Pulmonary Adaptation

Finland
Sture Andersson

Completed

Cesarean Section and Intestinal Flora of the Newborn (SECFLOR)

Intestinal Microbiome

Finland
Sure, Inc.
MaineHealth

Not yet recruiting

Evaluation of the Bexa™ Breast Examination (BBE)

Breast Cancer
George Washington University
Sure, Inc.

Terminated

Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography

Breast Cancer

United States
Cure&Sure Biotech Co., LTD
Beijing Tiantan Hospital

Completed

Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96

Glioma

China
Sure Med Compliance
National Institute on Drug Abuse (NIDA)

Recruiting

Comparing a Patient Self-Assessment Software to Treatment as Usual in Opioid Prescriber and Patient Opioid Outcomes

Chronic Pain | Opioid Use | Opioid-use Disorder | Opioid Misuse

United States
Chinese PLA General Hospital
Cure&Sure Biotech Co., LTD

Unknown

Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96

Gastric Carcinoma

China
Gerhard Andersson

Completed

Guided Internet-delivered Cognitive-behavioral Therapy for Former Chronic Pain Patients

Chronic Pain

Sweden
Gerhard Andersson

Completed

Guided Internet-delivered Acceptance and Commitment Therapy for Chronic Pain Patients

Chronic Pain
Cure&Sure Biotech Co., LTD
Beijing Tiantan Hospital; Shenzhen Second People's Hospital

Recruiting

A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96

Glioma of Brain

China
Cure&Sure Biotech Co., LTD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer

Liver Cancer
Cure&Sure Biotech Co., LTD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Unknown

Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96

Pancreatic Adenocarcinoma | Liver Cancer

China
M.D. Anderson Cancer Center

Not yet recruiting

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Mesonephric-like Adenocarcinoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

OligoProgressive Metastatic Disease

United States
M.D. Anderson Cancer Center

Not yet recruiting

Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer

Advanced Colorectal Cancer

United States
M.D. Anderson Cancer Center

Not yet recruiting

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Dyspnea

United States
M.D. Anderson Cancer Center

Not yet recruiting

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

Cancer | Occupational Therapy

United States
M.D. Anderson Cancer Center

Not yet recruiting

Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain

Hypophysectomy

United States
M.D. Anderson Cancer Center

Not yet recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

B-cell Acute Lymphocytic Leukemia | Relapsed/Refractory

United States
M.D. Anderson Cancer Center

Not yet recruiting

Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients

Mantle Cell Lymphoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

Familial Platelet Disorder | Hematopoietic

United States
M.D. Anderson Cancer Center

Recruiting

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

Intra-abdominal Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

Lymphoma

United States
M.D. Anderson Cancer Center

Not yet recruiting

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

Brain Malignancies | Pseudoprogression

United States
M.D. Anderson Cancer Center

Recruiting

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

Misuse, Opioid

United States
M.D. Anderson Cancer Center

Recruiting

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

Esophageal Cancer | Chemoradiation | Lymphopenia | Pneumococcal Vaccine

United States
M.D. Anderson Cancer Center

Recruiting

Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)

Oropharyngeal Neoplasms | Robotic Surgery and/or Radiotherapy | Lymphoscintigraphy

United States
M.D. Anderson Cancer Center

Recruiting

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

Head and Neck Squamous Cell Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

Prostate Cancer | Radical Prostatectomy

United States
M.D. Anderson Cancer Center

Recruiting

Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome

Pelvic Metastasis

United States
M.D. Anderson Cancer Center

Recruiting

A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases

Bone Metastases

United States
M.D. Anderson Cancer Center

Recruiting

Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy

Lymphoma

United States
M.D. Anderson Cancer Center

Recruiting

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Follicular Lymphoma

United States
M.D. Anderson Cancer Center

Recruiting

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma

United States
M.D. Anderson Cancer Center

Recruiting

Reminder Messages for Lung Cancer Screening

Lung Cancer | Skin Flaps

United States
M.D. Anderson Cancer Center

Recruiting

An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients

Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

Prostate Cancer

United States
M.D. Anderson Cancer Center

Recruiting

A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)

Acute Myeloid Leukemia

United States
M.D. Anderson Cancer Center

Recruiting

A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

Lymphomas | B-cell Lymphomas

United States
M.D. Anderson Cancer Center

Recruiting

A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)

Lung | Pulmonary

United States
M.D. Anderson Cancer Center

Recruiting

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

Spinal Disease

United States
M.D. Anderson Cancer Center

Recruiting

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Breast Cancer | Colorectal Cancer

United States
M.D. Anderson Cancer Center

Recruiting

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Hodgkin Lymphoma | B-Cell Lymphoma | Relapsed B-cell NHL

United States
M.D. Anderson Cancer Center

Recruiting

A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use

Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Renal Cell Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

Breast Carcinoma | Invasive Breast Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States
M.D. Anderson Cancer Center

Recruiting

Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla

Renal Medullary Carcinoma | Carcinomas

United States
M.D. Anderson Cancer Center

Recruiting

First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging

Endocrine Neoplasia

United States

3

Subscribe